​JZJT Pharmaceutical’s Revenue from Healthcare Products Decreased by 20%
date:2017-01-19
browse:(797)
Keyword:
In 2016, JZJT (600750)’s operating revenue decreased by 39.87%, realizing ¥1,562 million; whereas its net profit reached ¥380 million with a year-on-year growth of 3.47%. Regardless of the impact brought by the external transfer of Jiangxi Jointown Pharmaceutical in 2015, the operating revenue decreased by 12.09% on year-on-year basis.
Among which, the area of “healthcare food and others” relying mainly on Chuenu series and Shenlingcao Oral Liquid etc. realized annual operating revenue of ¥240 million which decreased by 23.33% year-on-year.
The latest article
Recommended enterprise
Back to top

个人用户请使用微信扫码登入
关闭